...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: you won’t see anyone buying this

in big volume or light volume for that matter for the simple reason that one of these days one of the many forward looking statements/lies/rumour mill BS spewed by this ceo might actually turn out to be the truth. I remain pessimistic & in total disgust of this fella.

 

Share
New Message
Please login to post a reply